From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future
From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future This article traces the evolution of API-in-capsule (AIC)...
What does Annex 1 mean for the cell & gene industry? Insights from 3P innovation.
The revision of EU GMP Annex 1 has redefined expectations for sterile manufacturing across the life sciences sector and nowhere is this felt more...
How do we reduce your Environmental Cost of Ownership (ECO)?
Today’s pharmaceutical landscape positions 'sustainability' as an operational imperative. Manufacturers face increasing regulatory, societal, and...